Chevron (NYSE:CVX) was upgraded today by JP Morgan (NYSE:JPM) to neutral from underweight with a price target of $120 price target, as the current stock price represents a good entry point for investors.
Shares are higher by about four tenths of a percent.
Merck (NYSE:MRK) was upgraded today by Citigroup (NYSE:C) from neutral to buy with a price target of $50, as new products should add to earnings in the coming quarters.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.